IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways
Our findings indicated that <i>IRAK3</i> could function as an independent prognostic predictor and an immunotherapeutic indicator in LUAD through involvement of multiple inflammation-related pathways.
Authors
- Zitong Li (ORCID: https://orcid.org/0000-0001-8469-7295)
- Jié He (ORCID: https://orcid.org/0000-0003-0327-8852)
- Wei Rao (ORCID: https://orcid.org/0000-0002-4168-0298)
- Shugeng Gao (ORCID: https://orcid.org/0000-0003-3171-5319)
- Zhen Zhang (ORCID: https://orcid.org/0000-0003-1344-9272)
- Hao Zhang (ORCID: https://orcid.org/0000-0002-4582-2556)
- Qi Xue (ORCID: https://orcid.org/0000-0003-4603-6634)
- Li Zhao (ORCID: https://orcid.org/0000-0002-1378-7434)
- Fei Shao (ORCID: https://orcid.org/0009-0003-6413-9933)
- Yang Zhou (ORCID: https://orcid.org/0000-0003-4160-0646)
- Tiejun Liu (ORCID: https://orcid.org/0000-0001-7428-7399)
- Fengwei Tan
- Wei Guo
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tlcr-24-391
- Citations
- 4
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.13